NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Codiak BioSciences Inc (NASDAQ: CDAK)

 
CDAK Technical Analysis
5
As on 6th Jun 2023 CDAK STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.08 & Strong Sell for SHORT-TERM with Stoploss of 8.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CDAKSTOCK Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month -0.01 -50.00
Volume 96692 1 Year -13.10 -99.92
52 Week High 13.39 | 52 Week Low 0.01
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CDAK
Daily Charts
CDAK
Intraday Charts
Whats New @
Bazaartrend
CDAK
Free Analysis
 
CDAK Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
CDAK Forecast May 2024
4th UP Forecast16.74
3rd UP Forecast11.37
2nd UP Forecast8.06
1st UP Forecast4.74
1st DOWN Forecast-4.72
2nd DOWN Forecast-8.04
3rd DOWN Forecast-11.35
4th DOWN Forecast-16.72
 
CDAK Weekly Forecast
4th UP Forecast4.31
3rd UP Forecast2.93
2nd UP Forecast2.08
1st UP Forecast1.23
1st DOWN Forecast-1.21
2nd DOWN Forecast-2.06
3rd DOWN Forecast-2.91
4th DOWN Forecast-4.29
 
CDAK Forecast2024
4th UP Forecast26.85
3rd UP Forecast18.24
2nd UP Forecast12.92
1st UP Forecast7.6
1st DOWN Forecast-7.58
2nd DOWN Forecast-12.9
3rd DOWN Forecast-18.22
4th DOWN Forecast-26.83
 
 
CDAK Other Details
Segment EQ
Market Capital 310403680.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CDAK Address
CDAK
 
CDAK Latest News
 
Your Comments and Response on Codiak BioSciences Inc
 
CDAK Business Profile
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12, an exosome therapeutic candidates, for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; exoASO-NLRP3 for multiple sclerosis, neuropathy, and neurodegeneration; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics, Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 35 Cambridge Park Drive, Cambridge, MA, United States, 02140
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service